NB
Norinchukin Bank Portfolio holdings
AUM $6.72B
1-Year Return
19.37%
This Quarter Return
+21.04%
1 Year Return
+19.37%
3 Year Return
+81.53%
5 Year Return
+130.2%
10 Year Return
+300.21%
AUM
$5.86B
AUM Growth
+$739M
(+14%)
Cap. Flow
-$289M
Cap. Flow
% of AUM
-4.93%
Top 10 Holdings %
Top 10 Hldgs %
56.2%
Holding
518
New
13
Increased
52
Reduced
443
Closed
5
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$49.2M |
| 2 |
Roper Technologies
ROP
|
+$11.9M |
| 3 |
DexCom
DXCM
|
+$3.23M |
| 4 |
Copart
CPRT
|
+$3.1M |
| 5 |
T-Mobile US
TMUS
|
+$2.31M |
Top Sells
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$229M |
| 2 |
Clorox
CLX
|
+$17.9M |
| 3 |
Apple
AAPL
|
+$10.5M |
| 4 |
Visa
V
|
+$5.53M |
| 5 |
Microsoft
MSFT
|
+$5.36M |
Sector Composition
| 1 | Technology | 13.61% |
| 2 | Healthcare | 7.9% |
| 3 | Consumer Staples | 5.56% |
| 4 | Industrials | 5.48% |
| 5 | Consumer Discretionary | 5.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Deere & Co
DE
$127B
| $17.2M | 0.29% |
109,621
+3,011
| +3% | +$473K |
|
52
Walmart
WMT
$827B
| $16.9M | 0.29% |
423,345
-55,035
| -12% | -$2.2M |
|
53
Exxon Mobil
XOM
$479B
| $16.8M | 0.29% |
376,385
-20,797
| -5% | -$930K |
|
54
Thermo Fisher Scientific
TMO
$179B
| $16.1M | 0.27% |
44,408
-850
| -2% | -$308K |
|
55
Pfizer
PFE
$136B
| $15.9M | 0.27% |
513,849
-21,052
| -4% | -$653K |
|
56
Chevron
CVX
$317B
| $15.9M | 0.27% |
178,470
-20,512
| -10% | -$1.83M |
|
57
PepsiCo
PEP
$193B
| $15.9M | 0.27% |
119,845
-1,562
| -1% | -$207K |
|
58
McDonald's
MCD
$216B
| $15.8M | 0.27% |
85,432
-18,337
| -18% | -$3.38M |
|
59
Agilent Technologies
A
$35.6B
| $15.5M | 0.26% |
175,658
-7,069
| -4% | -$625K |
|
60
Comcast
CMCSA
$120B
| $15.5M | 0.26% |
396,409
-1,851
| -0.5% | -$72.2K |
|
61
Coca-Cola
KO
$285B
| $15.4M | 0.26% |
343,978
-19,457
| -5% | -$869K |
|
62
Rollins
ROL
$27.3B
| $14.9M | 0.25% |
527,667
+1,623
| +0.3% | +$45.9K |
|
63
AbbVie
ABBV
$384B
| $14.4M | 0.25% |
147,128
+21,954
| +18% | +$2.16M |
|
64
Salesforce
CRM
$231B
| $14M | 0.24% |
74,620
+392
| +0.5% | +$73.4K |
|
65
Abbott
ABT
$229B
| $13.4M | 0.23% |
146,493
-1,411
| -1% | -$129K |
|
66
Danaher
DHR
$135B
| $13.1M | 0.22% |
83,825
-1,560
| -2% | -$245K |
|
67
Boeing
BA
$163B
| $12.5M | 0.21% |
68,252
-17,236
| -20% | -$3.16M |
|
68
Amgen
AMGN
$148B
| $12.1M | 0.21% |
51,419
-924
| -2% | -$218K |
|
69
IBM
IBM
$239B
| $11.9M | 0.2% |
102,839
-18,277
| -15% | -$2.11M |
|
70
Eli Lilly
LLY
$671B
| $11.6M | 0.2% |
70,721
-945
| -1% | -$155K |
|
71
Bristol-Myers Squibb
BMY
$94.3B
| $11.1M | 0.19% |
189,453
-8,779
| -4% | -$516K |
|
72
Broadcom
AVGO
$1.72T
| $11M | 0.19% |
349,830
-50
| -0% | -$1.58K |
|
73
JPMorgan Chase
JPM
$849B
| $10.4M | 0.18% |
110,669
-22,513
| -17% | -$2.12M |
|
74
Medtronic
MDT
$120B
| $10.3M | 0.18% |
112,273
-1,104
| -1% | -$101K |
|
75
Berkshire Hathaway Class B
BRK.B
$1.06T
| $9.89M | 0.17% |
55,389
-2,258
| -4% | -$403K |
|